Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd-R Burmester

Showing results (21-30 of 293) with videos related to

Pageof 30
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 22, 2023
Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What Have We Learned?Ali Berkant Avci, Eugen Feist, Gerd R Burmester
RMD Open|November 5, 2015
Biologicals in rheumatoid arthritis: current and futureAli Berkant Avci, Eugen Feist, Gerd-R Burmester
Arthritis Research & Therapy|January 18, 2011
Kitasato Symposium 2010: new prospects for cytokinesGerd R Burmester, Peter E Lipsky, Thomas Dörner, et al.
Arthritis Research & Therapy|January 8, 2008
Cells of the synovium in rheumatoid arthritis. MacrophagesRaimund W Kinne, Bruno Stuhlmüller, Gerd-R Burmester
Arthritis Research & Therapy|April 3, 2004
Multiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses: implications for arthritis and autoimmune diseasesMonika C Brunner-Weinzierl, Holger Hoff, Gerd-R Burmester
Arthritis Research & Therapy|November 11, 2010
The association between rheumatoid arthritis and periodontal diseaseJacqueline Detert, Nicole Pischon, Gerd R Burmester, et al.
Current Opinion in Rheumatology|April 23, 2004
Rheumatoid factor revisitedThomas Dörner, Karl Egerer, Eugen Feist, et al.
Current Opinion in Rheumatology|July 18, 2020
Role for antimalarials in the management of COVID-19Eva V Schrezenmeier, Gerd R Burmester, Kai-Uwe Eckardt, et al.
Arthritis Research & Therapy|July 1, 2004
Perspectives and limitations of gene expression profiling in rheumatology: new molecular strategiesThomas Häupl, Veit Krenn, Bruno Stuhlmüller, et al.
Autoimmunity Reviews|August 22, 2006
Immunopathologic role of B lymphocytes in rheumatoid arthritis: rationale of B cell-directed therapyLorena Martinez-Gamboa, Hans-Peter Brezinschek, Gerd R Burmester, et al.
Pageof 30

Showing results (21-30 of 293) with videos related to

Sort By:
Pageof 30
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 22, 2023
Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What Have We Learned?Ali Berkant Avci, Eugen Feist, Gerd R Burmester
RMD Open|November 5, 2015
Biologicals in rheumatoid arthritis: current and futureAli Berkant Avci, Eugen Feist, Gerd-R Burmester
Arthritis Research & Therapy|January 18, 2011
Kitasato Symposium 2010: new prospects for cytokinesGerd R Burmester, Peter E Lipsky, Thomas Dörner, et al.
Arthritis Research & Therapy|January 8, 2008
Cells of the synovium in rheumatoid arthritis. MacrophagesRaimund W Kinne, Bruno Stuhlmüller, Gerd-R Burmester
Arthritis Research & Therapy|April 3, 2004
Multiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses: implications for arthritis and autoimmune diseasesMonika C Brunner-Weinzierl, Holger Hoff, Gerd-R Burmester
Arthritis Research & Therapy|November 11, 2010
The association between rheumatoid arthritis and periodontal diseaseJacqueline Detert, Nicole Pischon, Gerd R Burmester, et al.
Current Opinion in Rheumatology|April 23, 2004
Rheumatoid factor revisitedThomas Dörner, Karl Egerer, Eugen Feist, et al.
Current Opinion in Rheumatology|July 18, 2020
Role for antimalarials in the management of COVID-19Eva V Schrezenmeier, Gerd R Burmester, Kai-Uwe Eckardt, et al.
Arthritis Research & Therapy|July 1, 2004
Perspectives and limitations of gene expression profiling in rheumatology: new molecular strategiesThomas Häupl, Veit Krenn, Bruno Stuhlmüller, et al.
Autoimmunity Reviews|August 22, 2006
Immunopathologic role of B lymphocytes in rheumatoid arthritis: rationale of B cell-directed therapyLorena Martinez-Gamboa, Hans-Peter Brezinschek, Gerd R Burmester, et al.
Pageof 30